DRAP Product.Enl No. 00411000344 Composition: Baryta OxalsuccinicaD200+200C, ThymolD200+200C, NaphthoquinoneD200+200C, SulphonamideD200+200C Specific Indication: Prostate cancer often does not cause symptoms for many years but when the symptoms appear the disease may have spread beyond the general prostatic disorders and the symptoms include frequent urination especially at night, inability to urinate, difficult to hold urine, a weak …










